LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 93 filers reported holding LYELL IMMUNOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $110,639,000 | +12.4% | 15,093,969 | 0.0% | 42.56% | +56.4% |
| Q2 2022 | $98,413,000 | +29.1% | 15,093,969 | 0.0% | 27.22% | +35.7% |
| Q1 2022 | $76,225,000 | -34.8% | 15,093,969 | 0.0% | 20.06% | +37.8% |
| Q4 2021 | $116,827,000 | -48.0% | 15,093,969 | -0.5% | 14.55% | -52.5% |
| Q3 2021 | $224,483,000 | -8.9% | 15,167,757 | 0.0% | 30.66% | -5.2% |
| Q2 2021 | $246,324,000 | – | 15,167,757 | – | 32.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 20,162,332 | $131,458,000 | 59.13% |
| Apoletto Ltd | 15,093,969 | $98,413,000 | 27.22% |
| Foresite Capital Management IV, LLC | 13,282,181 | $86,600,000 | 23.32% |
| MIC Capital Management UK LLP | 3,060,569 | $19,955,000 | 3.90% |
| Alphabet Inc. | 5,865,125 | $38,241,000 | 2.08% |
| HSG Holding Ltd | 3,045,997 | $19,860,000 | 1.83% |
| Board of Trustees of The Leland Stanford Junior University | 1,647,882 | $10,744,000 | 0.72% |
| SG3 Management, LLC | 600,000 | $3,912,000 | 0.46% |
| KETTLE HILL CAPITAL MANAGEMENT, LLC | 157,700 | $1,028,000 | 0.26% |
| Artal Group S.A. | 700,000 | $4,564,000 | 0.24% |